A synbiotic formula (SIM01) developed by Hong Kong firm GenieBiome in collaboration with the Chinese University of Hong Kong has been shown to alleviate multiple symptoms of post-acute COVID-19 syndrome (PACS), while also benefiting children after their COVID-19 vaccination.
Experimental drug that alters gut microbiome shows promise for long COVID relief medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.